Summary:
We INTRODUCTION Heparan sulfate (HS) is a major glycosaminoglycans (GAGs) component of the matrix of calcium oxalate (CaOx) stones and is a potent inhibitor of CaOx crystallization [1] [2] [3] . On the other hand, kidney stone formation is believed to proceed through a number of chemical, physicochemical, physiological and molecular mechanisms including crystal nucleation from supersaturated urine solutions, crystal growth and aggregation during transit through the nephron, crystal attachment to kidney epithelial cells and stone maturation [4] . CaOx crystal attachment on the renal tubular epithelial surface has been thought to be an important factor for initial microlith formation [5, 6] . Various types of cultured epithelial cell lines have been used to examine the mechanisms of crystal-cell interaction in "in vitro" studies. Mardin-Darby canine kidney (MDCK) cells have been used for studying the adhesion of crystals to epithelial cells [5] [6] [7] . Recently, several investigators have reported that presence of GAGs, such as HS and chondroitin sul fate (ChS) prevent crystal attachment to the tubular epithelial surface [6] [7] [8] . In general, GAGS are present in tissue as a proteoglycan. Free GAGs are metabolic turnover products of tissue proteoglycan, and appear in urine by glomeruler filtration. Unfortunately, pre vious reports failed to confirm the exact role of cell surface HS, because the wild type MDCK cells do not express any type of cell surface heparan sulfate proteoglycan (HSPG, syndecan) [9] . In the present study, we established a novel MDCK cell lines that expressed the human syndecan-1 gene and evaluated functions and morphological structures by using RT-PCR, western blotting, immunohistchemistry and HPLC. Moreover, we used this newly developed cell line to investigate the exact role of HS in the crystal attachment. In brief, subcloned human syndecan-1 cDNA was amplified by PCR. The PCR product was size fractionated by electrophoresis through 1.3% low melting agarose gel (FMC Bioproducts, Rockland, ME), the 943 by band isolated using the QIAquick DNA extraction kit (Qiagen, Inc), and ligated into the mammalian expression vector, pTARGET vector (Promega, Madison, WI) following by manufac- To evaluate the expression of human-syndecan-1 in the newly developed MDCK cells (KIC-synd-1), the following experiments were performed. In brief, 1 X 106 cells were harvested and their poly-(A+ )tailed RNA was isolated, then first strand cDNA was synthesized using manufacturer's protocol. RT-PCR was carried out by using the following primer pair; 5'-primer: 5'-ATGAGGCGCGCGGCGCTCTGG-3' specific for human syndecan-1 (206-226), 3'-primer: 5 '-TGCAGGGGTTGAGGTCTCATG-3 ' (689-709) [10] . To assess viability in the mRNA content, cyclophilin mRNA [12] was amplified simultaneously. The DNA sequences of primers for cyclophilin were as follows: 5'-primer: 5'-TTTATGTGTCAGGGTGGTGAC-TTCA-3' (192-216), 3'-primer: 5'-TATTCATGCCTTCTTTCACTTT-GC-3' (403-426). Detection and quantification of PCR products PCR products were resolved by electrophoresis through 1.3% agars gel containing anthodium bromide, and then visualized in UV light. The gels were scanned and the intensity of each PCR fragment was measured using an image analyzer (Gel Doc 1000, Bio Rad, Hercules, CA). Band intensities were normalized for differences in molecular weights. We also sequenced the PCR products and compared them with those of cDNA clone. 
MATERIALS AND METHODS

Cell
Crystal-cell interaction
Morphological aspects for crystal-cell interaction were evaluated by using scanning electron microscopy (SEM) as described by Ebisuno et al. [6] . In brief, confluent KIC-synd-1 cells on the 35 mm dish Falcon culture dishes (EASY GRIPTM, Becton Dickinson, NJ, USA) were rinsed twice rapidly with Hank's balanced salt solution (HBSS). The culture plate was then dipped vertically into a slowly stirred COM crystal suspension for 5 min. Removal of nonadherent crystals was obtained by washing the plate three times with HBSS. To perform SEM, the cells were fixed in 2.5% glutaralaldehyde in 0.05 M cacodylate buffer for 1 hr. After washing in 0.05 M cacodylate buffer three times, the samples were dehydrated through a graded series of ethanol and finally freeze dried. After mounting on stubs, the samples were supercoated with a conductive layer and examined using a Hitachi SEM 5000 (Hitachi, Tokyo, Japan). To evaluate the effect of HS on the cell surface, pretreatment of heparitinase for 15 min was performed before the experiment described above. 
RESULTS
Expression of human syndecan-i in MDCK cells
As shown in the top panel of Fig. 1 , human syndecan-1 gene was expressed in LNCaP cells, KICsynd-1 cells and human kidney tissue. In contrast, however, wild type MDCK cells did not express syndecan-1 gene. The PCR bands for cyclophilin (Fig. 1,  bottom panel) showed similar band intensities for the different cDNA preparations, indicating that similar amounts of cDNA were available. Figure 2 shows Western blot analysis in each cell lines. Both KICsynd-1 cells and LNCaP cells expressed syndecan-1 core protein. However, wild type MDCK cells did not produce syndecan-1 core protein. The localization of syndecan-1 on KIC-synd-1 cells and on wild type MDCK cells was confirmed by immunohistochemistry with anti-human syndecan-1 core protein monoclonal antibody. Syndecan-1 was significantly stained on the basolateral surface and cytosol in KIC-synd-1 cells. However, both wild type MDCK cells and negative control (without antibody) did not show any stain against syndecan-1 monoclonal antibody ( Fig There was no significant difference between these two cell lines. Figure  6 show SEM findings for crystal-cell interaction in wild type As shown in the top panel, KIC-synd-1 cells and LNCaP cells showed high expression of transfected human syndecan-1 gene, which appears as a band at 504 bp. In contrast, wild type MDCK cells did not express ,ynclecan-1 gene The PCR hands for cyclophilin (bottom panel) showed similar band intensities for the different cDNA preparations, indicating that similar amounts of cDNA were available. 
CHIKAMA
ET AL. Fig. 3 . The localization of syndecan-1 on KIC-synd-1 cells and on wild type MDCK cells were confirmed by immunohistochemistry with anti-human syndecan-1 core protein monoclonal antibody. Syndecan-1 was significantly stained on hasolaleral area and cytosol in KIC-synd-1 cells (arrow heads). However, both wild type MDCK cells and negative control (without antibody) did not show any stain against syndecan-1 monoclonal antibody. MDCK cells and KIC-synd-1 cells. Figures 6A and  B show SEM images after incubation with buffer in calcium oxalate monohydrate (COM) crystals for 5 min and subsequent removal of non-adherent crystals. Adherent COM crystals were rarely present on the KTC-synd-1 cells ( Figs. 6C and D) . On the other hand, after removal of cell surface HS by using heparitinase, the number of COM crystals apparently increased (Fig. 6E) . Moreover, many, crystals that overlapped aggregated with each other (Fig. 6F ). Its distribution is limited to epithelial cells. but it is also found in condensing mesenchyme during development and in pre-B lymphocytes and plasma cells [25] .
Transfection of syndecan-1 cDNA construct into NIH-3T3 fibroblasts (that normally produce low amounts of cell surface syndecan-1 ) has further been shown to result in increased binding domain of fibronectin [26] . On the other hand, the transfection of mutant syndecan-1 gene caused morphological and functional changes in MDCK cells and Chinese hamster ovary (CHO) cells [26, 27] . In the kidney. HS is the major acid GAGS constituent of both glomerular and tubular basement membranes [28] .
Moreover. previous reports indicated that GAGS play an important role in crystalcell interactions [5] [6] [7] [8] .
Removal of GAGs from urothelial cell Surfaces promotes crystal adhesion and the process is reversed by treatment with Sulfated polysaccharides such as heparin and chondroitin sulfate [8] . Pretreatment of CaOx crystals with sulfated GAGS prevents their adherence to LLC-PK1 and MDCK cells in culture [7] . Heparin also inhibits endocytosis of CaOx crystals on BSC-1 on monkey kidney epithelial cells via an interaction with the cells and not with the crystals [5] . In general, the MDCK cell line has been widely used in various experiments on kidney stone disease. However, wild type MDCK cells do not expresses any member of the syndecan family [9] . In this study, we established a new MDCK cell line that expresses human syn-Kurume Medical Journa l Vol. 49, No. 4, 2002 decan-1 gene in order to evaluate the role of heparan sulfate proteoglycan (HSPG) "in vitro". This newly established cell line (KIC-synd-1 cells) could produce both core protein and GAG chains. In particular, the total amount of HS chain increased significantly in KIC-synd-1 cells compared with wild type MDCK cells. These data suggest that HS coats the cell surface in KIC-synd-1 cells and protects the cell surface against crystal attachment. In fact, the number of cell-attached crystals was dramatically reduced in the KIC-synd-1 cells compared with MDCK cells. On the other hand, pretreatment with heparitinase caused an increase in number of cell-attached crystals. These data support the view that cell surface HS as well as syndecan-1 prevent COM crystal attachment via the creation of a charge barrier. Boeve' et al. [29] hypothesized that the role of GAGs on the CaOx crystallization and stone formation in urine is as follows; First, urinary GAGs inhibit crystal nucleation, growth and aggregation. Second, urinary GAGs prevent the crystal adherence on the renal tubular epithelial surface. Third, urinary GAGs are capable of correction for abnormal oxalate transport. Last, urinary GAGs have a protective effect on renal tissue against oxalate-induced cell injury. Recently, we have reported an increased expression of HSPG mRNA and production of HS chain in the nephrolithic rat kidney [30, 31] . The exact mechanism of the increase in the expression of the syndecan gene is unclear at present. The KIC-synd-1 cell line may be useful to investigate the role of syndecan during CaOx nephrolithiasis in vitro. 
